Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study
Journal of the European Academy of Dermatology and Venereology : JEADV（2023）
关键词
atopic dermatitis,tralokinumab,treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要